Advarra is attending the virtual Advanced Therapies Connect event on January 26-27, 2021. The two-day free event for members connects biopharma experts to interactive sessions on topics such as CAR-T cell therapy, diversity and inclusion, quality standardization, and patient safety. Contact us to discuss how Advarra’s Institutional Biosafety Committee (IBC) Services provides comprehensive review and oversight of clinical trials involving recombinant DNA, synthetic nucleic acid molecules, genetic engineering, and gene therapy research.